Where & When
Saturday, April 12, 2025
Detroit Marriott
200 W. Big Beaver Road
Troy, MI 48084
Registration
Don’t delay! Registration deadline is Thursday, April 10, 2025.
Register Now
Cost to attend is $125 for physicians and pharmacists; $50 for mid-level providers, retired physicians and other allied health providers; $25 for nurses and CTO staff. The conference is $20 for fellows, residents, and medical students, which is refundable upon attendance.
Target Audience
This program is geared towards general physicians, surgeons, fellows, residents, students, pathologists, radiation oncologists, pharmacists, physician assistants, nurse practitioners and nurses in the field of hematology and oncology.
Educational Objectives
Upon completion of this programs, the participant will:
- Integrate diagnostic and therapeutic strategies used in the multimodality treatment of patients with breast cancer.
- Specify the use of new agents, both cytotoxic and biologic, and their uses in treating breast cancer.
- Identify the latest research findings in all areas of breast cancers and how the updated research could impact future decision making in the diagnosis and treatment of these cancers.
Accreditation
This activity has been approved for AMA PRA Category 1 Credit™
Provided by Wayne State University School of Medicine and Karmanos Cancer Institute.
Agenda
8:00 - 8:50: Registration | Breakfast
8:50 - 9:00: Opening Remarks
Lydia Choi, M.D. and Hadeel Assad, M.D.
9:00 - 9:30: Updates onHER2+ Breast Cancer
Jailan Elayoubi, M.D.
Barbara Ann Karmanos Cancer Institute
9:30 - 10:00: Updates in Breast Reconstruction
Guillermina Nava, M.D.
Barbara Ann Karmanos Cancer Institute
10:00 - 11:00: Overview of Anthracycline Use in Breast Cancer
Sarah Hurvitz, M.D., FACP
Fred Hutchinson Cancer Center, Seattle, Washington
11:00 - 11:45: Case Presentations and Discussion Panel
Moderator: Lubina Arjyal, M.D., Barbara Ann Karmanos Cancer Institute
11:45-12:30: Lunch
12:30-1:30: DCIS
Kelly C. Hewitt, M.D., FACS (she/her)
Huntsman Cancer Institute at The University of Utah
Salt Lake City, Utah
1:30-2:00: Updates in ER+ and TNBC
Lawrence Flaherty, M.D.
Barbara Ann Karmanos Cancer Institute
2:00-2:30: Updates in Breast Cancer Radiotherapy
Brian Yeh, M.D., Ph.D..
Barbara Ann Karmanos Cancer Institute
2:30-3:00: Women's Wellness Clinic: Survivorship, High-Risk Screening
Amy Legghio, MSN, CNP, OCN
Barbara Ann Karmanos Cancer Institute
3:00: Closing Remarks
More Information
For any additional questions, please contact Pamela Sydorchuk, symposium coordinator, at symposium@karmanos.org or call 313-576-8746.